跳至主要内容
临床试验/EUCTR2008-005800-24-AT
EUCTR2008-005800-24-AT进行中(未招募)不适用

Characterisation of humoral and cellular immunity of low- and high-responder after TBE vaccination

Medizinische Universität Wien, Institut für Spezifische Prophylaxe und Tropenmedizin0 个研究点目标入组 84 人开始时间: 2008年9月22日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
84

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Adults (=18 years) of both sexes without upper age limit
  • Willingness to sign written informed consent form
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Age: < 18 years
  • Pregnancy or breast feeding
  • prior TBE infection
  • Acute infection at day of inclusion (day 0) (body temperature > 37.9°C )
  • Planned surgery within 2 weeks before/after any scheduled rabies vaccination during the entire study
  • Concomitant medication: systemic cortisone, immune suppressive therapy 4 weeks before or planned medication during the study
  • History of autoimmune disease
  • drug addiction
  • plasma donators
  • administration of other vaccines 4 weeks before/after day 0
  • Administration of immunoglobulins 6 weeks prior to any vaccination or blood donation during the entire study period
  • Specific Immune Therapy (Hypo-/Desensibilization) within 14 days before and after the 2 study vaccination doses.
  • History of any malignant disease 5 years prior to the study entry
  • Any contraindication for the administration of the TBE- or influenza vaccine according to the manufactures information.

研究者

发起方
Medizinische Universität Wien, Institut für Spezifische Prophylaxe und Tropenmedizin

相似试验

Characterisation of humoral and cellular immunity of... | 临床试验